The global urometer market is anticipated to grow at a considerable CAGR of 6.9% during the forecast period. The increasing cases of prostate cancer are expected to propel the growth of the global urometer market. Other than skin cancer, prostate cancer is the most common cancer in the US. According to the American Cancer Society (ACS), as of March 2022, around 268,490 new cases of prostate cancer and around 34,500 deaths from prostate cancer in the US. Prostate cancer is the 2nd most common cancer in men across the globe. It is also the second leading cause of cancer death in people in the US, behind only lung cancer. Moreover, about 1 man in 41 will die of prostate cancer. Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. Prostate cancer has many symptoms such as urinating often, especially at night, difficulty starting urination, pain or burning during urination, blood in the urine or semen, and others.
Browse the full report description of “Urometer Market Size, Share & Trends Analysis Report by Product (200 ML, 400 ML, 450 ML, 500 ML), by Application (Operative Procedures, Emergency Trauma, Palliative Care, and Others), and by (Hospitals, Clinics, Home Healthcare, and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/urometer-market
About 6 cases in 10 are diagnosed in men who are 65 or older, and it is rare in men under 40. The average age of men at diagnosis is about 66. Many men get urinary problems such as leaking urine, difficulty urinating and others as a side effect of their treatment. This is because prostate cancer treatment can damage the nerves and muscles that control when you urinate. Hence in these situations, the urometer can help in problems related to urination after or during the treatment. In addition, the survival rate of prostate cancer is also increasing, which is also boosting the demand for urometer in the market as the patients still have symptoms, according to the American Cancer Society (ACS), more than 3.1 million men in the US who have been diagnosed with prostate cancer at some point are still alive today. These strong factors promote the growth of the urometer across the globe.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including Becton Dickinson and Co., Cardinal Health, Inc., Convatec Inc., Forlong Medical Co., Ltd., Teleflex, Inc., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Urometer Market Report Segment
By Product
By Application
By End-User
Global Urometer Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/urometer-market